Boule Diagnostics AB (OTCPK:BDABF)
$ 7.84 0 (0%) Market Cap: 26.17 Mil Enterprise Value: 41.04 Mil PE Ratio: 0 PB Ratio: 1.08 GF Score: 69/100

Q3 2024 Boule Diagnostics AB Earnings Call Transcript

Oct 25, 2024 / 08:00AM GMT
Release Date Price: $7.84
Holger Lembrer
Boule Diagnostics AB - Chief Financial Officer

Good morning, everybody and welcome to the third quarter's earning call for bull diagnostics.

I'm Holger Lembrer CFO for both diagnostics. And with me, I have our CEO Torben Nielsen.

After our presentation of the third quarter's earnings, we will open up for questions. Please also feel free to type questions into the chat field with that. I'm leaving over to Torben.

Torben Nielsen
Boule Diagnostics AB - Chief Executive Officer

Thank you. Good morning and a warm welcome to everybody who's decided to join this Q3 earnings call. We'll begin by taking a look at the Q3 highlights.

Overall, it was a stable quarter in which we delivered slightly below. Last year.

Sales was negatively impacted by lower instrument and consumable sales.

Consumable sales was as expected impacted by the transition to license manufacturing model in India.

And we should expect to see this impact increase as we ramp up production in India for both consumables and in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot